BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11596461)

  • 21. Disorders of ketone production and utilization.
    Kayer MA
    Mol Genet Metab; 2006 Apr; 87(4):281-3. PubMed ID: 16622911
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitochondrial myopathies.
    DiMauro S
    Curr Opin Rheumatol; 2006 Nov; 18(6):636-41. PubMed ID: 17053512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipidic myopathies].
    Muñoz-Blanco JL
    Rev Neurol; 1998 Apr; 26 Suppl 1():S72-80. PubMed ID: 9810593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal pseudo-obstruction as a manifestation of impaired mitochondrial fatty acid oxidation.
    Gilbert J; Ibdah JA
    Med Hypotheses; 2005; 64(3):586-9. PubMed ID: 15617873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A defect in the transport of long-chain fatty acids associated with acute liver failure.
    Odaib AA; Shneider BL; Bennett MJ; Pober BR; Reyes-Mugica M; Friedman AL; Suchy FJ; Rinaldo P
    N Engl J Med; 1998 Dec; 339(24):1752-7. PubMed ID: 9845710
    [No Abstract]   [Full Text] [Related]  

  • 27. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry.
    Fukao T; Lopaschuk GD; Mitchell GA
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):243-51. PubMed ID: 14769483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic mitochondrial fatty acid oxidation disorders].
    Matsubara Y
    Ryoikibetsu Shokogun Shirizu; 1995; (8):312-6. PubMed ID: 8581639
    [No Abstract]   [Full Text] [Related]  

  • 29. Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.
    Roe CR
    Semin Neonatol; 2002 Feb; 7(1):37-47. PubMed ID: 12069537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36.
    Brinkmann JF; Abumrad NA; Ibrahimi A; van der Vusse GJ; Glatz JF
    Biochem J; 2002 Nov; 367(Pt 3):561-70. PubMed ID: 12088505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
    Virmani A; Gaetani F; Binienda Z
    Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid storage myopathies.
    Bruno C; Dimauro S
    Curr Opin Neurol; 2008 Oct; 21(5):601-6. PubMed ID: 18769256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial fatty acid oxidation and acute fatty liver of pregnancy.
    Treem WR
    Semin Gastrointest Dis; 2002 Jan; 13(1):55-66. PubMed ID: 11944635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
    Clark-Taylor T; Clark-Taylor BE
    Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
    Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketone body metabolism in lean and obese women.
    Vice E; Privette JD; Hickner RC; Barakat HA
    Metabolism; 2005 Nov; 54(11):1542-5. PubMed ID: 16253646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.